Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00652899
What this trial is testing

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 14
Testing effectiveness (Phase 2)UnknownNCT02805829
What this trial is testing

Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric Cancer

Who this might be right for
Gastric Cancer
Xuzhou Medical University 20
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Not applicableStudy completedNCT00540956
What this trial is testing

Natural Killer Cells in Older Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Institut Paoli-Calmettes 40
Not applicableStudy completedNCT02019628
What this trial is testing

Enhanced Natural Killer Cell Activity and RBAC

Who this might be right for
Family Member
University of Miami 20
Not applicableNot Yet RecruitingNCT06988072
What this trial is testing

Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia

Who this might be right for
BK PolyomavirusKidney Transplant
Assistance Publique - Hôpitaux de Paris 75
Not applicableStudy completedNCT02764281
What this trial is testing

MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal Type
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 53
Testing effectiveness (Phase 2)UnknownNCT02560441
What this trial is testing

Trial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type

Who this might be right for
Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
Chinese Academy of Medical Sciences
Testing effectiveness (Phase 2)UnknownNCT02688673
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With SCLC

Who this might be right for
Small- Cell Lung Cancer
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT07744256
What this trial is testing

Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)Relapsed/Refractory SCLCExtensive-stage SCLC
Beijing Biotech 60
Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)UnknownNCT01924156
What this trial is testing

DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT07759856
What this trial is testing

NK Cells Plus ICI for SCLC Maintenance

Who this might be right for
Small Cell Lung Cancer
Tianjin First Central Hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT07435701
What this trial is testing

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Who this might be right for
Ovarian Neoplasms MalignantAscites
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Early research (Phase 1)UnknownNCT05665075
What this trial is testing

Natural Killer (NK) Cell Therapy Targeting CD33 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 19
Early research (Phase 1)Study completedNCT00640796
What this trial is testing

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute, T-CellJuvenile Myelomonocytic Leukemia Lymphoblastic+2 more
St. Jude Children's Research Hospital 22
Post-approval studies (Phase 4)UnknownNCT01501136
What this trial is testing

Treatment of Natural Killer/T Cell Lymphoma-I/II

Who this might be right for
Nasal and Nasal-type NK/T-cell Lymphoma
Mingzhi Zhang 200
Early research (Phase 1)Study completedNCT04327037
What this trial is testing

Safety of Expanded Haploidentical Natural Killer Cells for Leukemia

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Acute Lymphoblastic
Belarusian Research Center for Pediatric Oncology, Hematology and Immunology 10
Not applicableUnknownNCT06160115
What this trial is testing

The Role of NK Cells to Detect Blood Infection in ALL.

Who this might be right for
Acute Lymphoblastic LeukemiaBloodstream Infection
Assiut University 56
Early research (Phase 1)Looking for participantsNCT06321484
What this trial is testing

Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian CancerRecurrent Ovary CancerOvarian Cancer+4 more
Dana-Farber Cancer Institute 18
Next Page